153 related articles for article (PubMed ID: 29577052)
1. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context.
Kichatova VS; Kyuregyan KK; Soboleva NV; Karlsen AA; Isaeva OV; Isaguliants MG; Mikhailov MI
J Immunol Res; 2018; 2018():7685371. PubMed ID: 29577052
[TBL] [Abstract][Full Text] [Related]
2. Impact of amino acid substitutions in hepatitis C virus core region on the severe oxidative stress.
Chida T; Watanabe S; Ohta K; Noritake H; Ito M; Suzuki T; Suda T; Kawata K
Free Radic Biol Med; 2024 Feb; 212():199-206. PubMed ID: 38103659
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.
Jaspe RC; Sulbarán YF; Sulbarán MZ; Loureiro CL; Rangel HR; Pujol FH
Virol J; 2012 Sep; 9():214. PubMed ID: 22995142
[TBL] [Abstract][Full Text] [Related]
4. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.
Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2011 Jun; 83(6):1016-22. PubMed ID: 21503914
[TBL] [Abstract][Full Text] [Related]
5. Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV.
Campos LB; de Almeida NAA; de Santana CG; Barbosa ENP; Horta MAP; Amendola Pires M; Brandão Mello CE; de Paula VS; de Barros JJF
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680226
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa.
Prabdial-Sing N; Blackard JT; Puren AJ; Mahomed A; Abuelhassan W; Mahlangu J; Vermeulen M; Bowyer SM
Antiviral Res; 2016 Mar; 127():90-8. PubMed ID: 26704023
[TBL] [Abstract][Full Text] [Related]
7. Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy.
Seko Y; Akuta N; Suzuki F; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Intervirology; 2013; 56(1):13-21. PubMed ID: 22907167
[TBL] [Abstract][Full Text] [Related]
8. Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.
Funaoka Y; Sakamoto N; Suda G; Itsui Y; Nakagawa M; Kakinuma S; Watanabe T; Mishima K; Ueyama M; Onozuka I; Nitta S; Kitazume A; Kiyohashi K; Murakawa M; Azuma S; Tsuchiya K; Watanabe M
J Virol; 2011 Jun; 85(12):5986-94. PubMed ID: 21490101
[TBL] [Abstract][Full Text] [Related]
9. Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2008 Aug; 80(8):1354-62. PubMed ID: 18551609
[TBL] [Abstract][Full Text] [Related]
10. Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.
Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2010 Apr; 82(4):575-82. PubMed ID: 20166188
[TBL] [Abstract][Full Text] [Related]
11. Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis.
Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Hara T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Hepatology; 2012 Dec; 56(6):2134-41. PubMed ID: 22806754
[TBL] [Abstract][Full Text] [Related]
12. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.
Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
Hepatology; 2007 Nov; 46(5):1357-64. PubMed ID: 17657816
[TBL] [Abstract][Full Text] [Related]
13. Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.
Ogura S; Akuta N; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Kobayashi M; Suzuki F; Suzuki Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Intervirology; 2009; 52(4):179-88. PubMed ID: 19546575
[TBL] [Abstract][Full Text] [Related]
14. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2009 Jun; 81(6):1032-9. PubMed ID: 19382270
[TBL] [Abstract][Full Text] [Related]
15. Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
Kobayashi M; Akuta N; Suzuki F; Hosaka T; Sezaki H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Mineta R; Iwasaki S; Miyakawa Y; Kumada H
J Med Virol; 2010 Jan; 82(1):41-8. PubMed ID: 19950230
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Zeuzem S; Lee JH; Roth WK
Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
[TBL] [Abstract][Full Text] [Related]
17. Interferon lambda and hepatitis C virus core protein polymorphisms associated with liver cancer.
Moreira JP; Malta Fde M; Diniz MA; Kikuchi L; Chagas AL; Lima Lde S; Gomes-Gouvêa MS; de Castro VF; Santana RA; Sumita NM; Paranagua Vezozzo DC; Carrilho FJ; Pinho JR
Virology; 2016 Jun; 493():136-41. PubMed ID: 27035616
[TBL] [Abstract][Full Text] [Related]
18. Kinetic response of wild and mutant core codon 70 strains of HCV genotype 1b to pegylated interferon-α and ribavirin therapy.
Hu Z; Liu Y; Qiu L; Fan Z; Nie W; Liang S; Jin R
Virol J; 2015 Dec; 12():220. PubMed ID: 26684004
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the STAT1‑interacting domain of the hepatitis C virus core protein modulate the response to antiviral therapy.
Anjum S; Afzal MS; Ahmad T; Aslam B; Waheed Y; Shafi T; Qadri I
Mol Med Rep; 2013 Aug; 8(2):487-92. PubMed ID: 23799612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]